LOGIN
REQUEST WALKTHROUGH
search
times
Invion Ltd.

INVION LTD.

 

(ASX: IVX)

Invion Ltd. (ASX: IVX) is a clinical-stage drug development company in the biotechnology and pharmaceutical industry in Australia. IVX has three key development programs: INV102 for inflammatory respiratory disease; INV104, a leukotriene receptor antagonist; and, INV103, a modified, naturally occurring human protein.

 

Company Articles

Newsletter

Keep me on top of the stock market news
New call-to-action